BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30539249)

  • 1. Serum tumor markers and testicular germ cell tumors: a primer for radiologists.
    Marshall C; Enzerra M; Rahnemai-Azar AA; Ramaiya NH
    Abdom Radiol (NY); 2019 Mar; 44(3):1083-1090. PubMed ID: 30539249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum human chorionic gonadotropin is associated with angiogenesis in germ cell testicular tumors.
    Arrieta O; Michel Ortega RM; Angeles-Sánchez J; Villarreal-Garza C; Avilés-Salas A; Chanona-Vilchis JG; Aréchaga-Ocampo E; Luévano-González A; Jiménez MA; Aguilar JL
    J Exp Clin Cancer Res; 2009 Aug; 28(1):120. PubMed ID: 19709439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The present and future of serum diagnostic tests for testicular germ cell tumours.
    Murray MJ; Huddart RA; Coleman N
    Nat Rev Urol; 2016 Dec; 13(12):715-725. PubMed ID: 27754472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and radiographic characterization of primary seminomas and nonseminomatous germ cell tumors.
    Gu L; Zhang L; Hou N; Li M; Shen W; Xie X; Teng Y
    Niger J Clin Pract; 2019 Mar; 22(3):342-349. PubMed ID: 30837421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.
    Dieckmann KP; Simonsen-Richter H; Kulejewski M; Anheuser P; Zecha H; Isbarn H; Pichlmeier U
    Biomed Res Int; 2019; 2019():5030349. PubMed ID: 31275973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options for stage I nonseminoma.
    Feldman DR
    J Clin Oncol; 2014 Dec; 32(34):3797-800. PubMed ID: 25366681
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
    Dieckmann KP; Radtke A; Geczi L; Matthies C; Anheuser P; Eckardt U; Sommer J; Zengerling F; Trenti E; Pichler R; Belz H; Zastrow S; Winter A; Melchior S; Hammel J; Kranz J; Bolten M; Krege S; Haben B; Loidl W; Ruf CG; Heinzelbecker J; Heidenreich A; Cremers JF; Oing C; Hermanns T; Fankhauser CD; Gillessen S; Reichegger H; Cathomas R; Pichler M; Hentrich M; Eredics K; Lorch A; Wülfing C; Peine S; Wosniok W; Bokemeyer C; Belge G
    J Clin Oncol; 2019 Jun; 37(16):1412-1423. PubMed ID: 30875280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
    Neumann A; Keller T; Jocham D; Doehn C
    Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Lactate Dehydrogenase in Identifying Relapse for Patients With Stage I Testicular Cancer on Surveillance.
    Bobrowski A; Anson-Cartwright L; Kuhathaas K; Jiang DM; Chung P; Bedard P; Warde P; O'Malley M; Sweet J; Hamilton RJ
    J Urol; 2022 Dec; 208(6):1250-1258. PubMed ID: 35997696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lactate dehydrogenase isoenzyme 1 and prediction of death in patients with metastatic testicular germ cell tumors.
    von Eyben FE; Blaabjerg O; Hyltoft-Petersen P; Madsen EL; Amato R; Liu F; Fritsche H
    Clin Chem Lab Med; 2001 Jan; 39(1):38-44. PubMed ID: 11256799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of alkaline phosphatase isoenzymes as tumor markers for testicular germ cell tumors.
    Koshida K; Nishino A; Yamamoto H; Uchibayashi T; Naito K; Hisazumi H; Hirano K; Hayashi Y; Wahren B; Andersson L
    J Urol; 1991 Jul; 146(1):57-60. PubMed ID: 1711586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactate dehydrogenase and its isoenzymes in testicular germ cell tumors: an overview.
    von Eyben FE
    Oncodev Biol Med; 1983; 4(6):395-414. PubMed ID: 6196755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testicular cancer. Clinical practice guidelines in oncology.
    Motzer RJ; Bolger GB; Boston B; Carducci MA; Fishman M; Hancock SL; Hauke RJ; Hudes GR; Jonasch E; Kantoff P; Kuzel TM; Lange PH; Levine EG; Logothetis C; Margolin KA; Pohar KS; Redman BG; Robertson CN; Samlowski WE; Sheinfeld J;
    J Natl Compr Canc Netw; 2006 Nov; 4(10):1038-58. PubMed ID: 17112452
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease.
    Gerl A; Clemm C; Lamerz R; Mann K; Wilmanns W
    Eur J Cancer; 1993; 29A(7):961-5. PubMed ID: 7684597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early clinical stages (CS1, CS1Mk+ and CS2A) of non-seminomatous testis cancer. Value of pre- and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastases. Swedish-Norwegian Testicular Cancer Project (SWENOTECA).
    Klepp O; Flodgren P; Maartman-Moe H; Lindholm CE; Unsgaard B; Teigum H; Fosså SD; Paus E
    Ann Oncol; 1990 Jul; 1(4):281-8. PubMed ID: 1702312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lactate dehydrogenase isoenzyme 1 and tumour volume are indicators of response to treatment and predictors of prognosis in metastatic testicular germ cell tumours.
    von Eyben FE; Blaabjerg O; Madsen EL; Petersen PH; Smith-Sivertsen C; Gullberg B
    Eur J Cancer; 1992; 28(2-3):410-5. PubMed ID: 1375486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the Serum Metallothionein Level Reflect the Stage of Testicular Germ Cell Tumor?
    Tariba B; Živković T; Filipović Marijić V; Erk M; Gamulin M; Pizent A
    Arch Med Res; 2016 Apr; 47(3):232-5. PubMed ID: 27255355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
    Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
    Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: correlation with tumor markers alpha-fetoprotein and human chorionic gonadotropin.
    Fottner C; Sattarova S; Hoffmann K; Spöttl G; Weber MM
    Eur J Endocrinol; 2008 Sep; 159(3):317-27. PubMed ID: 18524796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.